| |
Triple Negative
|
Luminal
|
|---|
|
miRNA ID
|
2^-(TNBC-C)A
|
p (Corr) TNBC vs CP
|
Regulation (TNBC vs C)
|
FC (TNBC vs C)F
|
2^-(L-C)B
|
p (Corr) L vs C P
|
Regulation (L vs C)
|
FC (L vs C)F
|
|---|
|
hsa-let-7b-5p
|
2.14
|
0.006
|
Up
|
2.14
|
2.29
|
0.000
|
Up
|
2.29
|
|
hsa-let-7c-5p
|
1.72
|
0.031
|
Up
|
1.72
|
1.95
|
0.001
|
Up
|
1.95
|
|
hsa-let-7i-5p
|
1.71
|
0.008
|
Up
|
1.71
|
1.60
|
0.008
|
Up
|
1.60
|
|
hsa-miR-15a-5p
|
2.01
|
0.006
|
Up
|
2.01
|
0.91
|
0.977
|
Up
|
−1.09
|
|
hsa-miR-16-5p
|
2.20
|
0.000
|
Up
|
2.20
|
1.68
|
0.008
|
Up
|
1.68
|
|
hsa-miR-195-5p
|
1.84
|
0.004
|
Up
|
1.84
|
1.60
|
0.011
|
Up
|
1.60
|
|
hsa-miR-199a-3p
|
0.36
|
0.002
|
Down
|
−2.81
|
0.36
|
0.003
|
Down
|
−2.80
|
|
hsa-miR-199a-5p
|
0.46
|
0.021
|
Down
|
−2.19
|
0.25
|
0.001
|
Down
|
−3.94
|
|
hsa-miR-19a-3p
|
1.81
|
0.006
|
Up
|
1.81
|
1.29
|
0.205
|
Up
|
1.29
|
|
hsa-miR-19b-3p
|
1.86
|
0.006
|
Up
|
1.86
|
1.27
|
0.203
|
Up
|
1.27
|
|
hsa-miR-210-3p
|
1.91
|
0.000
|
Up
|
1.91
|
1.23
|
0.646
|
Up
|
1.23
|
|
hsa-miR-22-3p
|
1.93
|
0.006
|
Up
|
1.93
|
1.08
|
0.083
|
Up
|
1.08
|
|
hsa-miR-25-3p
|
2.02
|
0.001
|
Up
|
2.02
|
2.01
|
0.001
|
Up
|
2.01
|
|
hsa-miR-29c-3p
|
1.66
|
1.010
|
Up
|
1.66
|
1.19
|
0.203
|
Up
|
1.19
|
|
hsa-miR-328-3p
|
1.58
|
0.563
|
Up
|
1.58
|
20.96
|
0.000
|
Up
|
20.96
|
|
hsa-miR-340-5p
|
0.65
|
0.043
|
Down
|
−1.54
|
0.55
|
0.008
|
Down
|
−1.81
|
|
hsa-miR-489-3p
|
1.85
|
0.057
|
Up
|
1.85
|
2.26
|
0.000
|
Up
|
2.26
|
|
hsa-miR-7-5p
|
2.30
|
0.003
|
Up
|
2.30
|
2.01
|
0.012
|
Up
|
2.01
|
-
TNBC Triple Negative Breast Cancer
- C - Disease-free individuals used as Controls
- L - Luminal Breast Cancer
-
A: 2^-(TNBC-N) represents 2^ddCt values of Triple Negative patient’s samples as compared to those of disease-free individuals
-
P: Corrected p-values ≤ 0.01 for a given pair of conditions are shown in bold
-
F: Fold change values ≥ 1.5 are shown in bold
-
B: 2^-(L-N) represents 2^ddCt values of Luminal patients’ samples as compared to those disease-free individuals
